QQQ   416.27 (-1.69%)
AAPL   164.62 (-1.45%)
MSFT   398.90 (-1.33%)
META   481.97 (-3.95%)
GOOGL   153.12 (-1.85%)
AMZN   174.66 (-2.54%)
TSLA   148.65 (-0.85%)
NVDA   810.00 (-4.34%)
AMD   148.61 (-4.17%)
NIO   3.82 (-4.50%)
BABA   68.57 (-0.45%)
T   16.33 (+0.00%)
F   12.08 (+0.17%)
MU   106.92 (-4.48%)
GE   148.19 (-3.11%)
CGC   8.02 (+2.43%)
DIS   111.78 (-0.58%)
AMC   3.26 (+11.64%)
PFE   25.77 (+1.50%)
PYPL   61.98 (-0.19%)
XOM   119.94 (+1.20%)
QQQ   416.27 (-1.69%)
AAPL   164.62 (-1.45%)
MSFT   398.90 (-1.33%)
META   481.97 (-3.95%)
GOOGL   153.12 (-1.85%)
AMZN   174.66 (-2.54%)
TSLA   148.65 (-0.85%)
NVDA   810.00 (-4.34%)
AMD   148.61 (-4.17%)
NIO   3.82 (-4.50%)
BABA   68.57 (-0.45%)
T   16.33 (+0.00%)
F   12.08 (+0.17%)
MU   106.92 (-4.48%)
GE   148.19 (-3.11%)
CGC   8.02 (+2.43%)
DIS   111.78 (-0.58%)
AMC   3.26 (+11.64%)
PFE   25.77 (+1.50%)
PYPL   61.98 (-0.19%)
XOM   119.94 (+1.20%)
QQQ   416.27 (-1.69%)
AAPL   164.62 (-1.45%)
MSFT   398.90 (-1.33%)
META   481.97 (-3.95%)
GOOGL   153.12 (-1.85%)
AMZN   174.66 (-2.54%)
TSLA   148.65 (-0.85%)
NVDA   810.00 (-4.34%)
AMD   148.61 (-4.17%)
NIO   3.82 (-4.50%)
BABA   68.57 (-0.45%)
T   16.33 (+0.00%)
F   12.08 (+0.17%)
MU   106.92 (-4.48%)
GE   148.19 (-3.11%)
CGC   8.02 (+2.43%)
DIS   111.78 (-0.58%)
AMC   3.26 (+11.64%)
PFE   25.77 (+1.50%)
PYPL   61.98 (-0.19%)
XOM   119.94 (+1.20%)
QQQ   416.27 (-1.69%)
AAPL   164.62 (-1.45%)
MSFT   398.90 (-1.33%)
META   481.97 (-3.95%)
GOOGL   153.12 (-1.85%)
AMZN   174.66 (-2.54%)
TSLA   148.65 (-0.85%)
NVDA   810.00 (-4.34%)
AMD   148.61 (-4.17%)
NIO   3.82 (-4.50%)
BABA   68.57 (-0.45%)
T   16.33 (+0.00%)
F   12.08 (+0.17%)
MU   106.92 (-4.48%)
GE   148.19 (-3.11%)
CGC   8.02 (+2.43%)
DIS   111.78 (-0.58%)
AMC   3.26 (+11.64%)
PFE   25.77 (+1.50%)
PYPL   61.98 (-0.19%)
XOM   119.94 (+1.20%)
Free Trial
NASDAQ:SNMX

Senomyx (SNMX) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)
Free SNMX Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$1.49
▼
$1.49
50-Day Range
N/A
52-Week Range
$0.83
▼
$1.71
Volume
N/A
Average Volume
151,720 shs
Market Capitalization
$72.03 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
SNMX stock logo

About Senomyx Stock (NASDAQ:SNMX)

Senomyx, Inc. discovers, develops, and commercializes flavor ingredients and natural high intensity sweeteners primarily for the packaged food, beverage, and ingredient supply industries in the United States. The company develops and/or commercializes sweet, savory and salt flavor ingredients, bitter blockers and cooling agents. It sells various flavor ingredients directly to flavor companies. The company has collaboration agreements with Ajinomoto Co., Inc.; Firmenich SA; and PepsiCo, Inc. Senomyx, Inc. was founded in 1998 and is headquartered in San Diego, California.

SNMX Stock News Headlines

December 9, 2023 | morningstar.com
AKD Securities Ltd Ordinary Shares AKDSL
July 19, 2023 | investing.com
NZ Automotive Investments Ltd (NZA)
April 19, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
March 30, 2023 | thestreet.com
McKesson Inc. (MCK): Today's Featured Wholesale Laggard
February 23, 2023 | usatoday.com
Fact check: Fetal tissue not in your food, drinks, experts say
June 2, 2022 | thestreet.com
How to Get Stock Exposure to Gluten-Free Movement
January 29, 2022 | fool.com
Senomyx, Inc.(SNMX)
See More Headlines
Receive SNMX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Senomyx and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/02/2018
Today
4/19/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Consumer Staples
Industry
Commercial Physical Research
Sub-Industry
N/A
Current Symbol
NASDAQ:SNMX
CUSIP
N/A
CIK
1123979
Web
www.senomyx.com
Phone
858-646-8300
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-1,260,000.00
Net Margins
-9.11%
Pretax Margin
N/A
Return on Equity
-15.80%
Return on Assets
-10.48%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.35
Quick Ratio
3.92

Sales & Book Value

Annual Sales
$29.32 million
Price / Sales
2.46
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.39 per share
Price / Book
3.82

Miscellaneous

Outstanding Shares
48,340,000
Free Float
N/A
Market Cap
$72.03 million
Optionable
Optionable
Beta
1.33
Beginners Guide To Retirement Stocks Cover
Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. John W. Poyhonen (Age 58)
    Pres, CEO & Director
  • Mr. David C. Humphrey (Age 49)
    VP & CFO
  • Ms. Catherine C. Lee (Age 44)
    Sr. VP, Gen. Counsel & Corp. Sec.
  • Ms. Sharon Wicker (Age 62)
    Sr. VP & Chief Commercial Devel. Officer
  • Ms. Susan Firestone Melody
    VP of HR

Key Competitors

View All Competitors

SNMX Stock Analysis - Frequently Asked Questions

How were Senomyx's earnings last quarter?

Senomyx, Inc. (NASDAQ:SNMX) announced its quarterly earnings data on Thursday, August, 2nd. The specialty chemicals company reported ($0.08) earnings per share for the quarter, beating the consensus estimate of ($0.09) by $0.01. The specialty chemicals company earned $3.29 million during the quarter. Senomyx had a negative trailing twelve-month return on equity of 15.80% and a negative net margin of 9.11%.

What other stocks do shareholders of Senomyx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Senomyx investors own include Aralez Pharmaceuticals (ARLZ), Heron Therapeutics (HRTX), Novavax (NVAX), Rexahn Pharmaceuticals (REXN), Vical (VICL), (CASC) (CASC), DURECT (DRRX), Idera Pharmaceuticals (IDRA), Inovio Pharmaceuticals (INO) and Lexicon Pharmaceuticals (LXRX).

This page (NASDAQ:SNMX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
How Biden has already won 2024
Porter & Company
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
My biggest AI fear
Paradigm Press
Options trading has suddenly become more reliable.
Eagle Publishing